patientpressure

144 results found.

Top Stocks matching your search for "patient pressure"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 15, 2023

$SAVA “Treatment also eased depression and dementi... See more

Feb, 1, 2023

This will bring in billions of revenue and it will... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 5, 2023

I’m sure patient will rewards high.

Nov, 11, 2022

$HKD I wonder how long they will hold it I’m super... See more

Image with triangles

Divihomes is Now Live

Check out our new advanced search tool that can help you find the best home services in your area.

Search & Match

Instant Communication

Phone Image with DiviHomes website

Unbiased Reviews

100% Free

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Nov, 10, 2022

$SLRX 'We believe this interim data is an e... See more

Oct, 28, 2022

$SLRX “These initial data explain why we believ... See more

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 15, 2023

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

Feb, 1, 2023

This will bring in billions of revenue and it will make the life quality longer for AD patients.

Jan, 29, 2023

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

Jan, 18, 2023

CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

Jan, 11, 2023

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

Jan, 9, 2023

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

Jan, 6, 2023

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

Dec, 30, 2022

but mostly new hope for all the families and patients with AZ.

Dec, 29, 2022

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 5, 2023

I’m sure patient will rewards high.

Nov, 11, 2022

$HKD I wonder how long they will hold it I’m super patient I will be holding & adding more by days I’m not leaving 😂 soon or later it will eventually explode 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Nov, 10, 2022

$SLRX 'We believe this interim data is an encouraging development for these patients in need of new treatment options and we are looking forward to an additional data update next month.”

Oct, 28, 2022

$SLRX “These initial data explain why we believe SP-3164 is so exciting, with the potential to make a positive difference in the treatment of hematologic cancers.